Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1

Yuan Shih Hu, Jeehaeh Do, Chandrakanth Reddy Edamakanti, Ameet R. Kini, Marco Martina, Samuel Stupp, Puneet Opal

Research output: Contribution to journalArticle

Abstract

There is increasing appreciation for the role of the neurovascular unit in neurodegenerative diseases. We showed previously that the angiogenic and neurotrophic cytokine, vascular endothelial growth factor (VEGF), is suppressed to abnormally low levels in spinocerebellar ataxia type 1 (SCA1), and that replenishing VEGF reverses the cerebellar pathology in SCA1 mice. In that study, however, we used a recombinant VEGF, which is extremely costly to manufacture and biologically unstable as well as immunogenic. To develop a more viable therapy, here we test a synthetic VEGF peptide amphiphile that self-assembles into nanoparticles. We show that this nano-VEGF has potent neurotrophic and angiogenic properties, is well-tolerated, and leads to functional improvement in SCA1 mice even when administered at advanced stages of the disease. This approach can be generalized to other neurotrophic factors or molecules that act in a paracrine manner, offering a novel therapeutic strategy for neurodegenerative conditions.

Original languageEnglish (US)
Pages (from-to)312-321
Number of pages10
JournalBrain
Volume142
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Spinocerebellar Ataxias
Nanoparticles
Vascular Endothelial Growth Factor A
Nerve Growth Factors
Neurodegenerative Diseases
Pathology
Cytokines
Peptides
Therapeutics

Keywords

  • VEGF
  • nanoparticle
  • neurodegeneration
  • neurotrophic therapy
  • spinocerebellar ataxia type 1

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Hu, Yuan Shih ; Do, Jeehaeh ; Edamakanti, Chandrakanth Reddy ; Kini, Ameet R. ; Martina, Marco ; Stupp, Samuel ; Opal, Puneet. / Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1. In: Brain. 2019 ; Vol. 142, No. 2. pp. 312-321.
@article{f5db8c86da084ab0ad13a896d189b028,
title = "Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1",
abstract = "There is increasing appreciation for the role of the neurovascular unit in neurodegenerative diseases. We showed previously that the angiogenic and neurotrophic cytokine, vascular endothelial growth factor (VEGF), is suppressed to abnormally low levels in spinocerebellar ataxia type 1 (SCA1), and that replenishing VEGF reverses the cerebellar pathology in SCA1 mice. In that study, however, we used a recombinant VEGF, which is extremely costly to manufacture and biologically unstable as well as immunogenic. To develop a more viable therapy, here we test a synthetic VEGF peptide amphiphile that self-assembles into nanoparticles. We show that this nano-VEGF has potent neurotrophic and angiogenic properties, is well-tolerated, and leads to functional improvement in SCA1 mice even when administered at advanced stages of the disease. This approach can be generalized to other neurotrophic factors or molecules that act in a paracrine manner, offering a novel therapeutic strategy for neurodegenerative conditions.",
keywords = "VEGF, nanoparticle, neurodegeneration, neurotrophic therapy, spinocerebellar ataxia type 1",
author = "Hu, {Yuan Shih} and Jeehaeh Do and Edamakanti, {Chandrakanth Reddy} and Kini, {Ameet R.} and Marco Martina and Samuel Stupp and Puneet Opal",
year = "2019",
month = "2",
day = "1",
doi = "10.1093/brain/awy328",
language = "English (US)",
volume = "142",
pages = "312--321",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "2",

}

Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1. / Hu, Yuan Shih; Do, Jeehaeh; Edamakanti, Chandrakanth Reddy; Kini, Ameet R.; Martina, Marco; Stupp, Samuel; Opal, Puneet.

In: Brain, Vol. 142, No. 2, 01.02.2019, p. 312-321.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1

AU - Hu, Yuan Shih

AU - Do, Jeehaeh

AU - Edamakanti, Chandrakanth Reddy

AU - Kini, Ameet R.

AU - Martina, Marco

AU - Stupp, Samuel

AU - Opal, Puneet

PY - 2019/2/1

Y1 - 2019/2/1

N2 - There is increasing appreciation for the role of the neurovascular unit in neurodegenerative diseases. We showed previously that the angiogenic and neurotrophic cytokine, vascular endothelial growth factor (VEGF), is suppressed to abnormally low levels in spinocerebellar ataxia type 1 (SCA1), and that replenishing VEGF reverses the cerebellar pathology in SCA1 mice. In that study, however, we used a recombinant VEGF, which is extremely costly to manufacture and biologically unstable as well as immunogenic. To develop a more viable therapy, here we test a synthetic VEGF peptide amphiphile that self-assembles into nanoparticles. We show that this nano-VEGF has potent neurotrophic and angiogenic properties, is well-tolerated, and leads to functional improvement in SCA1 mice even when administered at advanced stages of the disease. This approach can be generalized to other neurotrophic factors or molecules that act in a paracrine manner, offering a novel therapeutic strategy for neurodegenerative conditions.

AB - There is increasing appreciation for the role of the neurovascular unit in neurodegenerative diseases. We showed previously that the angiogenic and neurotrophic cytokine, vascular endothelial growth factor (VEGF), is suppressed to abnormally low levels in spinocerebellar ataxia type 1 (SCA1), and that replenishing VEGF reverses the cerebellar pathology in SCA1 mice. In that study, however, we used a recombinant VEGF, which is extremely costly to manufacture and biologically unstable as well as immunogenic. To develop a more viable therapy, here we test a synthetic VEGF peptide amphiphile that self-assembles into nanoparticles. We show that this nano-VEGF has potent neurotrophic and angiogenic properties, is well-tolerated, and leads to functional improvement in SCA1 mice even when administered at advanced stages of the disease. This approach can be generalized to other neurotrophic factors or molecules that act in a paracrine manner, offering a novel therapeutic strategy for neurodegenerative conditions.

KW - VEGF

KW - nanoparticle

KW - neurodegeneration

KW - neurotrophic therapy

KW - spinocerebellar ataxia type 1

UR - http://www.scopus.com/inward/record.url?scp=85060803730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060803730&partnerID=8YFLogxK

U2 - 10.1093/brain/awy328

DO - 10.1093/brain/awy328

M3 - Article

VL - 142

SP - 312

EP - 321

JO - Brain

JF - Brain

SN - 0006-8950

IS - 2

ER -